Role of cadmium and arsenic as endocrine disruptors in the metabolism of carbohydrates: Inserting the association into perspectives.


Journal

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 17 12 2018
revised: 13 03 2019
accepted: 19 03 2019
pubmed: 29 3 2019
medline: 31 8 2019
entrez: 29 3 2019
Statut: ppublish

Résumé

Endocrine disrupting chemicals (EDCs) have widespread environmental distribution originated from both natural and anthropogenic sources. From the last few decades, their contamination has been raised dramatically owing to continuous discharge in sewage and untreated industrial effluents. They have rapidly gained a considerable attention due to their critical role in the development of multiple endocrine-related disorders notably diabetes mellitus (DM). Cadmium and arsenic, among the most hazardous EDCs, are not only widely spread in our environment, but they are also found to be associated with wide range of health hazards. After entering into the human body, they are preferably accumulated in the liver, kidney and pancreas where they exhibit deleterious effects on carbohydrate metabolism pathways notably glycolysis, glucogenesis and gluconeogenesis through the modification and impairment of relevant key enzymes activity. Impairment of hepatic glucose homeostasis plays a crucial role in the pathogenesis of DM. Along with compromised function of pancreas and muscles, diminished liver and kidney functions also contribute considerably to increase the blood glucose level. These metals have potential to bring conformational changes in these enzymes and make them inactive. Additionally, these metals also disturb the hormonal balance, such as insulin, glucocorticoids and catecholamines; by damaging pancreas and adrenal gland, respectively. Moreover, these metals also enhance the production of reactive oxygen species and depress the anti-oxidative defense mechanism with subsequent disruption of multiple organs. In this article, we have briefly highlighted the impact of arsenic and cadmium on the metabolism of carbohydrates and the enzymes that are involved in carbohydrate metabolism and glucose homeostasis.

Identifiants

pubmed: 30921704
pii: S0753-3322(18)38632-3
doi: 10.1016/j.biopha.2019.108802
pii:
doi:

Substances chimiques

Endocrine Disruptors 0
Environmental Pollutants 0
Cadmium 00BH33GNGH
Glucose IY9XDZ35W2
Arsenic N712M78A8G

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

108802

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Auteurs

Shakila Sabir (S)

Department of Pharmaceutical Chemistry, Government College University Faisalabad, Pakistan; Department of Pharmacology, Government College University Faisalabad, Pakistan.

Muhammad Sajid Hamid Akash (MSH)

Department of Pharmaceutical Chemistry, Government College University Faisalabad, Pakistan. Electronic address: sajidakash@gcuf.edu.pk.

Fareeha Fiayyaz (F)

Department of Pharmaceutical Chemistry, Government College University Faisalabad, Pakistan; Department of Microbiology, Government College University Faisalabad, Pakistan.

Uzma Saleem (U)

Department of Pharmacology, Government College University Faisalabad, Pakistan.

Malik Hassan Mehmood (MH)

Department of Pharmacology, Government College University Faisalabad, Pakistan.

Kanwal Rehman (K)

Institute of Pharmacy, Physiology and Pharmacy, University of Agriculture, Faisalabad, Pakistan. Electronic address: kanwal.akash@uaf.edu.pk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH